Cargando…
Beta‐cell replacement strategies for diabetes
Diabetes is characterized by elevated levels of blood glucose as a result of insufficient production of insulin from loss or dysfunction of pancreatic islet β‐cells. Here, we review several approaches to replacing β‐cells that were recently discussed at a symposium held in Kyoto, Japan. Transplant o...
Autores principales: | Kieffer, Timothy J, Woltjen, Knut, Osafune, Kenji, Yabe, Daisuke, Inagaki, Nobuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934267/ https://www.ncbi.nlm.nih.gov/pubmed/28984038 http://dx.doi.org/10.1111/jdi.12758 |
Ejemplares similares
-
iPSC technology‐based regenerative therapy for diabetes
por: Kondo, Yasushi, et al.
Publicado: (2017) -
Circadian rhythms and diabetes
por: Kurose, Takeshi, et al.
Publicado: (2011) -
β cell replacement therapy for the cure of diabetes
por: Lee, Joonyub, et al.
Publicado: (2022) -
Circadian Regulation of the Pancreatic Beta Cell
por: Seshadri, Nivedita, et al.
Publicado: (2021) -
Mitochondrial replacement by genome transfer in human oocytes: Efficacy, concerns, and legality
por: Yamada, Mitsutoshi, et al.
Publicado: (2020)